Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption

被引：0
|
作者：
Steven G. Allen
Chao Zhang
Shawn Malone
Soumyajit Roy
Robert T. Dess
William C. Jackson
Rohit Mehra
Corey Speers
Arul M. Chinnaiyan
Yilun Sun
Daniel E. Spratt
机构：
[1] University of Michigan,Department of Radiation Oncology
[2] Ottawa Hospital Research Institute,Department of Radiation Oncology, The Ottawa Hospital Cancer Center
[3] University of Michigan,Department of Pathology
[4] Case Western Reserve University,Department of Radiation Oncology, UH Seidman Cancer Center
[5] University of Michigan,Rogel Cancer Center and Michigan Center for Translational Pathology
[6] Case Western Reserve University,Department of Population Quantitative Health Sciences
来源：
World Journal of Urology | 2023年 / 41卷
关键词：
Prostate cancer; Androgen receptor; Adjuvant hormone therapy; Radiotherapy; Homologous recombination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3877 / 3887
页数：10
相关论文
共 50 条
  • [1] Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption
    Allen, Steven G.
    Zhang, Chao
    Malone, Shawn
    Roy, Soumyajit
    Dess, Robert T.
    Jackson, William C.
    Mehra, Rohit
    Speers, Corey
    Chinnaiyan, Arul M.
    Sun, Yilun
    Spratt, Daniel E.
    WORLD JOURNAL OF UROLOGY, 2023, 41 (12) : 3877 - 3887
  • [2] Impact Of Sequencing Of Androgen Receptor-Signaling Inhibition (ARSI) And Ionizing Radiotherapy (RT) In Prostate Cancer: Importance Of Homologous Recombination (HR) Disruption
    Allen, S. G.
    Zhang, C.
    Speers, C.
    Malone, S.
    Roy, S.
    Dess, R. T.
    Jackson, W. C.
    Wahl, D. R.
    Mehra, R.
    Alumkal, J.
    Sandler, H. M.
    Roach, M., III
    Sun, Y.
    Lawton, C. A. F.
    Feng, F. Y.
    Chinnaiyan, A.
    Spratt, D. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E853 - E853
  • [3] Next-Generation Androgen Receptor-Signaling Inhibitors for Prostate Cancer: Considerations for Older Patients
    Feng, Zizhen
    Graff, Julie N.
    DRUGS & AGING, 2021, 38 (02) : 111 - 123
  • [4] Next-Generation Androgen Receptor-Signaling Inhibitors for Prostate Cancer: Considerations for Older Patients
    Zizhen Feng
    Julie N. Graff
    Drugs & Aging, 2021, 38 : 111 - 123
  • [5] Impact of Sequencing of Androgen Suppression and Radiotherapy on Testosterone Recovery in Localized Prostate Cancer
    Roy, S.
    Grimes, S.
    Eapen, L.
    Spratt, D. E.
    Malone, J.
    Morgan, S. C.
    Malone, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E867 - E867
  • [6] Androgen receptor signaling in prostate cancer
    Zoran Culig
    Frédéric R. Santer
    Cancer and Metastasis Reviews, 2014, 33 : 413 - 427
  • [7] Androgen receptor signaling in prostate cancer
    Culig, Zoran
    Santer, Frederic R.
    CANCER AND METASTASIS REVIEWS, 2014, 33 (2-3) : 413 - 427
  • [8] Regulation of androgen receptor signaling in prostate cancer
    Dehm, SM
    Tindall, DJ
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (01) : 63 - 74
  • [9] Androgen receptor signaling and mutations in prostate cancer
    Koochekpour, Shahriar
    ASIAN JOURNAL OF ANDROLOGY, 2010, 12 (05) : 639 - 657
  • [10] PARP Inhibition in Prostate Cancer With Homologous Recombination Repair Alterations
    von Werdt, Alexander
    Brandt, Laura
    Scharer, Orlando D.
    Rubin, Mark A.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1639 - 1649
12345